Immunotherapy for recurrent miscarriage

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 10, 2014, Pages

  Wong, Luchin F ^a,b   Porter, T Flint ^a,b   Scott, James R ^b  

^a INTERMOUNTAIN HEALTHCARE   (United States)

^b UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIRTH RATE; GESTATIONAL AGE; HUMAN; IMMUNIZATION; IMMUNOTHERAPY; INTENTION TO TREAT ANALYSIS; LIVE BIRTH; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; SPONTANEOUS ABORTION; SYSTEMATIC REVIEW; THERAPY EFFECT; TROPHOBLAST; WHITE CELL IMMUNIZATION; ABORTION, HABITUAL; FEMALE; META ANALYSIS; PREGNANCY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC);

ABORTION, HABITUAL; FEMALE; HUMANS; IMMUNOTHERAPY; PREGNANCY; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84965190746     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD000112.pub3     Document Type: Review

References (94)

1. Cauchi MN. Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology 1994;32:263.
2. Cauchi MN, Lim D, Young DE, Kloss M, Pepperell RJ. Treatment of recurrent aborters by immunization with paternal cells - controlled trial. American Journal of Reproductive Immunology 1991;25:16-7.
3. Christiansen OB, Christiansen BS, Husth M, Mathiesen O, Lauritsen J, Grunnet N. Prospective study of anticardiolipin antibodies in immunized and untreated women with recurrent spontaneous abortions. Fertility and Sterility 1992;58:328-34.
4. Christiansen OB, Mathiesen O, Husth M, Lauritsen JG, Grunnet J. Placebo-controlled trial of active immunization with third party leukocytes in recurrent miscarriage. Acta Obstetricia et Gynecologica Scandinavica 1994;3:261-8.
5. Christiansen OB, Mathiesen O, Husth M. Intravenous immunoglobulin treatment of women with recurrent miscarriage. Acta Obstetricia et Gynecologica Scandinavica 1997;76:2.
6. Christiansen OB, Mathieson O, Husth M, Rasmussen K, Ingerslev JH, Lauritsen JG, et al. Placebo-controlled trial of treatment of unexplained secondary recurrent spontaneous abortions and recurrent late spontaneous abortions with iv immunoglobulin. Human Reproduction 1995;10:2690-5.
7. Christiansen OB, Pedersen B, Rosgaard A, Husth. A randomized, double-blind, placebo-controlled trial of intravenous immunoglobulin in the prevention of recurrent miscarriage: evidence for a therapeutic effect in women with secondary recurrent miscarriage. Human Reproduction 2002;17(3):809-16.
8. Coulam CB. Alternative treatment to lymphocyte immunization for treatment of recurrent spontaneous abortion. Immunotherapy with intravenous immunoglobulin for treatment of recurrent pregnancy loss: American experience. American Journal of Reproductive Immunology 1994;32:286-9.
9. Coulam CB. Immunotherapy with intravenous immunoglobulin for treatment of recurrent pregnancy loss: American experience. International Journal of Gynecology and Obstetrics 1994;46:47.
10. Coulam CB, Krysa L, Stern JJ, Bustillo M. Intravenous immunoglobulin for treatment of recurrent pregnancy loss. American Journal of Reproductive Immunology 1995;34:333-7.
11. Coulam CB, Stern JJ, Bustillo M. Ultrasonographic findings of pregnancy losses after treatment for recurrent pregnancy loss: intravenous immunoglobulin vs placebo. Fertility and Sterility 1994;61:248-51.
12. Gatenby PA. Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology 1994;32:263-4.
13. Gatenby PA, Cameron K, Simes RJ, Adelstein S, Bennett MJ, Jansen RPS, et al. Treatment of recurrent spontaneous abortion by immunization with paternal lymphocytes: results of a controlled trial. American Journal of Reproductive Immunology 1993;29:88-94.
14. German RSA/IVIG Group. Intravenous immunoglobulin for treatment of recurrent miscarriage. British Journal of Obstetrics and Gynaecology 1994;101:1072-7.
15. Ho HN, Gill TJ. Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology 1994;32:269-70.
16. Ho HN, Gill TJ, Hsieh HJ, Jiang JJ, Lee TY, Hsieh CY. Immunotherapy for recurrent spontaneous abortions in a Chinese population. American Journal of Reproductive Immunology 1991;25:10-5.
17. Illeni MT, Marelli G, Parazzini F, Acaia B, Bocciolone L, Bontempelli M, et al. Immunotherapy and recurrent abortion: a randomized clinical trial. Human Reproduction 1994;9:1247-9.
18. Parazzini F. Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology 1994;32:265.
19. Jablonowska B, Selbing A, PalfiM, Ernerudh J, Kjellberg S, Lindton B. Prevention of recurrent spontaneous abortion by intravenous immunoglobulin: a double-blind placebo-controlled study. Human Reproduction 1999;14:838-41.
20. Johnson PM, Ramsden GH, Chia KV, Hart CA, Farquharson RG, Francis WJA. A combined randomised double-blind and open study of trophoblast membrane infusion (TMI) in unexplained recurrent miscarriage. In: Chaouat G, Mowbray J editor(s). Cellular Molecular Biology of the Materno-Fetal Relationship. Vol. 212, Colloque INSERM/John Libbey Eurotext Ltd, 1991:277-84.
21. Kilpatrick DC. Department of Transfusion Medicine, The Royal Infirmary, Edinburgh EH3 9HB, Scotland. Personal communication 1994.
22. Kilpatrick DC, Liston W. Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology 1994;32:264.
23. Mowbray JF, Gibbings C, Liddell H, Reginald PW, Underwood JL, Beard RW. Controlled trial of treatment of recurrent spontaneous abortion by immunisation with paternal cells. Lancet 1985;1:941-3.
24. Mowbray JF, Underwood JL. Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology 1994;32:261.
25. Karrison TG, Ober C. Recurrent miscarriage (remis) study: how should data from women who do not become pregnant be handled?. Controlled Clinical Trials 1998;19:430-9.
26. Ober C, Karrison T, Odem RB, Barnes RB, Branch DW, Stephenson MD. Mononuclear-cell immunisation in prevention of recurrent miscarriages: a randomised trial. Lancet 1999;354:365-9.
27. Pandey MK, Agrawal S. Induction of MLR-Bf and protection of fetal loss: a current double blind randomized trial of paternal lymphocyte immunization for women with recurrent spontaneous abortion. International Immunopharmacology 2004;4:289-98.
28. Pandey MK, Thakur S, Agrawal S. Lymphocyte immunotherapy and its probable mechanism in the maintenance of pregnancy in women with recurrent spontaneous abortion. Archives of Gynecology and Obstetrics 2004;269:161-72.
29. Perino A, Vassiliadis A, Vuceticha R, Colacurci N, Menato G, Cignitti M, et al. Short-term therapy for recurrent abortion using intravenous immunoglobulins: results of a double-blind placebo-controlled Italian study. Human Reproduction 1997;12:2388-92.
30. ReznikoffMF. INTS [Laboratoire], 6 rue Cabanel, 75015 Paris, France. Personal communication 1994.
31. Reznikoff-Etievant MF. Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology 1994;32:266-7.
32. Scott JR, Branch WD, Dudley D. Department of Obstetrics and Gynecology, University of Utah Medical Center, Salt Lake City, Utah 84132, USA. Personal communication 1994.
33. Scott JR, Branch WD, Dudley DJ, Hatasaka HH. Immunotherapy for recurrent pregnancy loss: the University of Utah perspective. In: Dondero F, Johnson P editor(s). Reproductive Immunology. Serono Symposium Publications, Raven Press, 1997:255-7.
34. Stephenson MD, Dreher K, Houlihan E, Wu V. Prevention of unexplained recurrent spontaneous abortion using intravenous immunoglobulin: a prospective, randomized, double blinded, placebo controlled trial. American Journal of Reproductive Immunology 1998;39:82-8.
35. Stray-Pederson S. Department of Obstetrics and Gynecology, University of Oslo, Oslo, 1 Norway. Personal communication 1994.
36. Aoki K. Abstracts of contributors' individual data submitted to the worldwide prospective observation study on immunotherapy for treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology 1994;32:268.
37. Aoki K, Kajiura S, Matsumoto Y, Yagami Y. Clinical evaluation of immunotherapy in early pregnancy with x-irradiated paternal mononuclear cells for primary recurrent aborters. American Journal of Obstetrics and Gynecology 1993;169:649-53.
38. Check JH, Tarquini P, Gandy P, Lauer C. A randomized study comparing the efficacy of reducing the spontaneous abortion rate following lymphocyte immunotherapy and progesterone treatment vs progesterone alone in primary habitual aborters. Gynecologic and Obstetric Investigation 1995;39:257-61.
39. Christiansen OB, Christiansen BS, Husth M, Mathiesen O, Lauritsen J, Grunnet N. Prospective study of anticardiolipin antibodies in immunized and untreated women with recurrent spontaneous abortions. Fertility and Sterility 1992;58:328-34.
40. Cowchock FS, Smith JB. Fertility among women with recurrent spontaneous abortions - the effect of paternal cell immunization treatment. American Journal of Reproductive Immunology 1995;33:176-81.
41. Kilpatrick DC, Kitchin AJ, Liston WA. Humoral immune response to lymphocyte antigens in early pregnancy and after leucocyte immunotherapy. Journal of Obstetrics and Gynaecology 1993;13:77-81.
42. Kim CH, Lee KH, Kim SH, Chae HD, Kang BM, Jung KS. Effect of etanercept treatment in women with unexplained primary recurrent pregnancy loss. Human Reproduction 2012;27(Suppl 2):P098.
43. Kwon SK, Kim CH, Ahn JW, Lee KH, Chae HD, Kang BM. Effect of intravenous immunoglobulin on pregnancy outcome following IVF/ICSI in infertile patients with endometriosis. Fertility and Sterility 2012;98 Suppl 1(3):S263 Abstract no:O-511.
44. Li D, Li C, Zhu Y. Comparative study of the third party and paternal leukocyte immunization in recurrent spontaneous abortion of lowered maternal-fetal immuno-recognition. Chinese Journal of Obstetrics and Gynecology 1998;33:597-600.
45. Mahmoud F, Diejomaoh M, Omu A, Abul H, Haines D. Effect of IgG therapy on lymphocyte subpopulations in the peripheral blood of Kuwaiti women experiencing recurrent pregnancy loss. Gynecologic and Obstetric Investigation 2004;58(2):77-83.
46. Quenby S. A randomised controlled trial of prednisolone for women with recurrent miscarriage and high levels of uterine natural killer cells in the endometrium. Current Controlled Trials (www.controlled-trials.com/) (accessed 30 October 2007).
47. Redman CWG. UK multicenter paternal cell immunization trial. Nuffeld Department of Obstetrics and Gynecology Maternity Department, John Radcliffe Hospital, Headington, Oxford OX3 9DU. Personal communication 1996.
48. Sagot P, Bignon JD, Cesbron A, Laurent FX, Adjou C, Muller JY. Immunological treatment of spontaneous repeated abortions. The value of transfusing the partner's leukocytes in the third week of gestation. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction 1993;22:471-5.
49. Scarpellini F, Sbracia M. Use of granulocyte colony-stimulating factor for the treatment of unexplained recurrent miscarriage: a randomised controlled trial. Human Reproduction 2009;24(11):2703-8. [PUBMED: 19617208]
50. Scarpellini F, Sbracia M. Granulocyte colony-stimulating factor for the treatment of recurrent miscarriage. Journal of Reproductive Immunology 2011;90(2):158-9.
51. Stephenson M, Houlihan E, Daya S, Claman P, Graves G, Kutteh W. Intravenous immunoglobulin (IVIG) for treatment of unexplained secondary recurrent miscarriage: a prospective, randomized, double blinded, placebo-controlled trial. Frontiers in Fetal Health 2001;3(4):105-6.
52. Stephenson MD, Kutteh WH, Purkiss S, Librach C, Schultz P, Houlihan E, et al. Intravenous immunoglobulin and idiopathic secondary recurrent miscarriage: a multicentered randomized placebo-controlled trial. Human Reproduction 2010;25(9):2203-9.
53. Tang AW, Alfirevic Z, Turner MA, Drury J, Quenby S. Prednisolone Trial: Study protocol for a randomised controlled trial of prednisolone for women with idiopathic recurrent miscarriage and raised levels of uterine natural killer (uNK) cells in the endometrium. Trials 2009;10:102.
54. Tang AW, Alfirevic Z, Turner MA, Drury J, Topping J, Dawood F, et al. A pilot, double blind randomised controlled trial of prednisolone for women with recurrent miscarriage and raised uterine natural killer cell density. Human Reproduction 2011;26(Suppl 1):i48-9.
55. Tang AW, Alfirevic Z, Turner MA, Drury JA, Small R, Quenby S. A feasibility trial of screening women with idiopathic recurrent miscarriage for high uterine natural killer cell density and randomizing to prednisolone or placebo when pregnant. Human Reproduction 2013;28(7):1743-52.
56. Sun X-G, Liu X-Y, Zhu R, Fan G-S, Zhang Y, Chen F-L. Effectiveness of intravenous immunoglobulin therapy in treating unexplained recurrent spontaneous abortion and its effect on the level of serum soluble human leucocyte antigen G. Acta Academiae Medicinae Sinicae 2010;32(5):483-7.
57. Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nature Immunology 2004;5:266-71.
58. Aoki K, Kajiura S, Matsumoto Y, Ogasawara M, Okada S, Yagami Y, et al. Preconceptional natural-killer-cell activity as a predictor of miscarriage. Lancet 1995;345:1340-2.
59. Clark DA, Daya S. Trials and tribulations in the treatment of recurrent spontaneous abortion. American Journal of Reproductive Immunology 1991;25:18-24.
60. Clark DA, Coulam CB. Is there an immunological cause of repeated pregnancy wastage?. Advances in Obstetrics and Gynaecology 1995;3:321-42.
61. Collins J, Roberts R. Immunotherapy for recurrent spontaneous abortion: analysis 1. American Journal of Reproductive Immunology 1994;32:275-80.
62. Copp AJ. Death before birth: clues from gene knockouts and mutations. Trends in Genetics 1995;11(3):87-93.
63. Coulam CB. Epidemiology of recurrent spontaneous abortion. American Journal of Reproductive Immunology 1991;26:23-7.
64. Coulam CB. Immunologic tests in the evaluation of reproductive disorders: a critical review. American Journal of Obstetrics and Gynecology 1992;167:1844-51.
65. Coulam CB, Clark DA, Collins J, Scott JR. Worldwide collaborative observational study and meta-analysis on allogenic leukocyte immunotherapy for recurrent spontaneous abortion. American Journal of Reproductive Immunology 1994;32:55-72.
66. Daya S, Gunby J, Clark DA. Intravenous immunoglobulin therapy for recurrent spontaneous abortion: a meta-analysis. American Journal of Reproductive Immunology 1998;39:69-76.
67. Daya S, Gunby J, Porter F, Scott J, Clark DA. Critical analysis of intravenous immunoglobulin therapy for recurrent miscarriage. Human Reproduction Update 1999;5(5):475-82.
68. Duhem C, Dicato MA, Ries F. Side-effects of intravenous immunoglobulins. Clinical and Experimental Immunology 1994;97:79-83.
69. Fraser EJ, Grimes DA, Schultz KF. Immunization as therapy for recurrent spontaneous abortion: a review and meta-analysis. Obstetrics & Gynecology 1993;82:854-9.
70. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 [updated May 2005]. In: The Cochrane Library, Issue 3, 2005. Chichester, UK: John Wiley & Sons, Ltd.
71. Higgins JPT, Green S, editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
72. Hill JA. Immunological mechanisms of pregnancy maintenance and failure: a critique of theories and therapy. American Journal of Reproductive Immunology 1990;22:33-42.
73. Johnson PM. Pregnancy immunology. Fetal Maternal Medicine Review 1992;4:1-14.
74. Kwak JY, Kwak FMY, Ainbinder SW, Ruiz AM, Beer AG. Elevated peripheral blood natural killer cells are effectively suppressed by immunoglobulin G infusions in women with recurrent spontaneous abortion. American Journal of Reproductive Immunology 1996;35(4):363-9.
75. Mellor AL, Sivakumar J, Chandler P, Smith K, Molina H, Mao D, et al. Prevention of T cell-driven complement activation and inflammation by tryptophan catabolism during pregnancy. Nature Immunology 2001;2:64-8.
76. Morikawa M, Yamada H, Kato EH, Shimada S, Ebina Y, Yamada T, et al. NK cell activity and subsets in women with a history of spontaneous abortion. Cause, number of abortions, and subsequent pregnancy outcome. Gynecologic and Obstetric Investigation 2001;52:163-7.
77. Morikawa M, Yamada H, Kato EH, Shimada S, Kishi T, Yamada T, et al. Massive intravenous immunoglobulin treatment in women with four or more recurrent spontaneous abortions of unexplained etiology: down-regulation of NK cell activity and subsets. American Journal of Reproductive Immunology 2001;46:399-404.
78. Pegoraro E, Whitaker J, Mowery-Ruston, Surti U, Lanasa M, Hoffman EP. Familial skewed X inactivation: a molecular trait associated with high spontaneous-abortion rate maps to Xq28. American Journal of Human Genetics 1997;61:160-70.
79. Quenby S, Vince G, Farquharson R, Aplin J. Recurrent miscarriage: a defect in nature's quality control?. Human Reproduction 2002;17(8):1959-63.
80. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
81. Rossant J, Cross JC. Placental development: lessons from mouse mutants. Nature Reviews Genetics 2001;2:538-48.
82. Ruiz JE, Kwak JYH, Baum L, Gilmansachs A, Beaman KD, Kim YB, et al. Effects of intravenous immunoglobulin G on natural killer cell cytotoxicity in vitro in women with recurrent spontaneous abortion. Journal of Reproductive Immunology 1996;31:125-41.
83. Salmon JE. A noninflammatory pathway of pregnancy loss: innate immune inactivation?. Journal of Clinical Investigation 2004;114:15-7.
84. Scott JR, Rote NS, Branch DW. Immunologic aspects or recurrent abortion and fetal death. Obstetrics & Gynecology 1987;70:645-56.
85. Scott JR, Branch WD. Potential alloimmune factors and immunotherapy in recurrent miscarriage. Clinical Obstetrics and Gynecology 1995;37:761-7.
86. Smith JB, Cowchock FS. Immunological studies in recurrent spontaneous abortion: effects of immunization of women with paternal mononuclear cells on lymphocytotoxic and mixed lymphocyte reaction blocking antibodies and correlation with sharing of HLA and pregnancy outcome. Journal of Reproductive Immunology 1988;14:99-113.
87. Spandidos DA, Koumantakis E, Sifakis S, Sourvinos G. Microsatellite mutations in spontaneously aborted embryos. Fertility and Sterility 1998;70(5):892-5.
88. Sandercock P, Algra A, Anderson C, Bath P, Bereczki D, Berge E, et al. Stroke Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)). The Cochrane Library 2005, Issue2.
89. Tempfer C, Unfried G, Zeillinger R, Hefler L, Nagele F, Huber JH. Endothelial nitric oxide synthase gene polymorphism in women with idiopathic recurrent miscarriage. Human Reproduction 2001;16(8):1644-7.
90. Tsai AF, Kaufman KA, Walker MA, Karrison TG, Odem RB, Barnes RB, et al. Transmission disequilibrium of maternally-inherited CTLA-4 microsatellite alleles in idiopathic recurrent miscarriage. Journal of Reproductive Immunology 1998;40(2):147-57.
91. Xu C, Mao D, Holers VM, Palanca B, Cheng AM, Molina H. A critical role for murine complement regulator crry in fetomaternal tolerance. Science 2000;287:498-501.
92. Yamada H, Morikawa M, Kato EH, Shimada S, Kobashi G, Minakami H. Pre-conceptional natural killer cell activity and percentage as predictors of biochemical pregnancy and spontaneous abortion with normal chromosome karyotype. American Journal of Reproductive Immunology 2003;50:351-4.
93. Porter TF, LaCoursiere Y, Scott JR. Immunotherapy for recurrent miscarriage. Cochrane Database of Systematic Reviews 2006, Issue 2. [DOI: 10.1002/14651858.CD000112.pub2]
94. Scott JR. Immunotherapy for recurrent miscarriage. Cochrane Database of Systematic Reviews 2003, Issue 1. [DOI: 10.1002/14651858.CD000112]